Inventor · disambiguated record
Harald Rau
Also filed as: RAU HARALD
68 granted patents·46 pending applications·1,109 citations·filing 1980–2025
99Inventor score
Files withASCENDIS PHARMA AS28ASCENDIS PHARMA GROWTH DISORDERS AS23RAU HARALD9ASCENDIS PHARMA ENDOCRINOLOGY DIV A/S7GOLDSCHMIDT AG TH7
Top patents by PatentIndex Score
114 records- 0197US11154593B2CNP prodrugs with large carrier moietiesASCENDIS PHARMA GROWTH DISORDERS AS·Filed 2021·Granted Oct 26, 2021·13 cites·28 claims
- 0297US10835578B2CNP prodrugs with large carrier moietiesASCENDIS PHARMA GROWTH DISORDERS AS·Filed 2017·Granted Nov 17, 2020·21 cites·20 claims
- 0397US9056126B2Hydrogel formulationsHERSEL ULRICH·Filed 2011·Granted Jun 16, 2015·59 cites·23 claims
- 0497US5910564APolyamino acid ester copolymersGOLDSCHMIDT AG TH·Filed 1996·Granted Jun 8, 1999·157 cites·10 claims
- 0595US12156917B2CNP prodrugs with carrier attachment at the ring moietyASCENDIS PHARMA GROWTH DISORDERS AS·Filed 2022·Granted Dec 3, 2024·2 cites·13 claims
- 0695US8906847B2Prodrug comprising a drug linker conjugateCLEEMANN FELIX·Filed 2009·Granted Dec 9, 2014·86 cites·37 claims
- 0795US5828991ASentence reconstruction using word ambiguity resolutionUNIV NEW YORK STATE RES FOUND·Filed 1995·Granted Oct 27, 1998·254 cites·15 claims
- 0894US9919033B2Dry growth hormone composition transiently linked to a polymer carrierASCENDIS PHARMA ENDOCRINOLOGY DIV A/S·Filed 2016·Granted Mar 20, 2018·10 cites·20 claims
- 0993US12083182B2Controlled-release CNP agonists with increased NEP stabilityASCENDIS PHARMA GROWTH DISORDERS AS·Filed 2021·Granted Sep 10, 2024·3 cites·15 claims
- 1091US9511122B2Dry growth hormone composition transiently linked to a polymer carrierRASMUSSEN GRETHE NØRSKOV·Filed 2010·Granted Dec 6, 2016·16 cites·36 claims
- 1190US12133883B2Polymeric hGH prodrugsASCENDIS PHARMA ENDOCRINOLOGY DIV A/S·Filed 2020·Granted Nov 5, 2024·2 cites·21 claims
- 1290US11389510B2Controlled-release CNP agonists with low initial NPR-B activityASCENDIS PHARMA GROWTH DISORDERS AS·Filed 2017·Granted Jul 19, 2022·5 cites·6 claims
- 1390US10960053B2PEGylated recombinant human growth hormone compoundsASCENDIS PHARMA ENDOCRINOLOGY DIV A/S·Filed 2018·Granted Mar 30, 2021·5 cites·13 claims
- 1490US8377917B2Polymeric prodrug with a self-immolative linkerCOMPLEX BIOSYSTEMS GMBH·Filed 2005·Granted Feb 19, 2013·23 cites·36 claims
- 1589US11413351B2CNP prodrugs with carrier attachment at the ring moietyASCENDIS PHARMA GROWTH DISORDERS AS·Filed 2017·Granted Aug 16, 2022·7 cites·17 claims
- 1689US10799563B2Polymeric hGH prodrugsASCENDIS PHARMA ENDOCRINOLOGY DIV A/S·Filed 2015·Granted Oct 13, 2020·10 cites·21 claims
- 1789US9173953B2Prodrugs containing an aromatic amine connected by an amido bond to a linkerRAU HARALD·Filed 2010·Granted Nov 3, 2015·22 cites·20 claims
- 1889US2025127797A1Prodrug comprising a drug-linker conjugateASCENDIS PHARMA AS·Filed 2024·Application pending·0 cites
- 1989US2025127859A1Cnp prodrugs with large carrier moietiesASCENDIS PHARMA GROWTH DISORDERS AS·Filed 2024·Application pending·0 cites
- 2088US12239689B2Controlled-release CNP agonists with low initial NPR-B activityASCENDIS PHARMA GROWTH DISORDERS AS·Filed 2022·Granted Mar 4, 2025·1 cites·10 claims
- 2188US11389511B2Controlled-release CNP agonists with reduced side-effectsASCENDIS PHARMA GROWTH DISORDERS AS·Filed 2017·Granted Jul 19, 2022·7 cites·16 claims
- 2288US11224661B2Controlled-release CNP agonists with increased NEP stabilityASCENDIS PHARMA GROWTH DISORDERS AS·Filed 2017·Granted Jan 18, 2022·7 cites·13 claims
- 2388US10682395B2Dry growth hormone composition transiently linked to a polymer carrierASCENDIS PHARMA ENDOCRINOLOGY DIV·Filed 2018·Granted Jun 16, 2020·5 cites·22 claims
- 2488US9272048B2PEGylated recombinant human growth hormone compoundsRAU HARALD·Filed 2009·Granted Mar 1, 2016·15 cites·37 claims
- 2588US9062094B2Dipeptide-based prodrug linkers for aliphatic amine-containing drugsRAU HARALD·Filed 2011·Granted Jun 23, 2015·15 cites·15 claims
- 2687US9278139B2Sterilization of biodegradable hydrogelsASCENDIS PHARMA AS·Filed 2015·Granted Mar 8, 2016·7 cites·17 claims
- 2787US7968085B2Hydrogel formulationsASCENDIS PHARMA AS·Filed 2004·Granted Jun 28, 2011·37 cites·16 claims
- 2887US2025090671A1Cnp prodrugsASCENDIS PHARMA GROWTH DISORDERS AS·Filed 2024·Application pending·0 cites
- 2986US2025032587A1Novel Polymeric hGH ProdrugsASCENDIS PHARMA ENDOCRINOLOGY DIV A/S·Filed 2024·Application pending·0 cites
- 3086US2024316153A1Cnp prodrugs with large carrier moietiesASCENDIS PHARMA GROWTH DISORDERS AS·Filed 2024·Application pending·0 cites
- 3185US11311604B2Controlled-release CNP agonists with low NPR-C bindingASCENDIS PHARMA GROWTH DISORDERS AS·Filed 2017·Granted Apr 26, 2022·6 cites·10 claims
- 3285US10980860B2Diagnosis, prevention and treatment of diseases of the jointASCENDIS PHARMA AS·Filed 2013·Granted Apr 20, 2021·11 cites·15 claims
- 3385US10098930B2PEGylated Recombinant Human Growth Hormone CompoundsASCENDIS PHARMA GROWTH DISORDERS DIV A/S·Filed 2016·Granted Oct 16, 2018·10 cites·12 claims
- 3485US9457066B2Prodrugs comprising an insulin linker conjugateSANOFI AVENTIS DEUTSCHLAND·Filed 2015·Granted Oct 4, 2016·6 cites·24 claims
- 3585US5960385ASentence reconstruction using word ambiguity resolutionUNIV NEW YORK STATE RES FOUND·Filed 1998·Granted Sep 28, 1999·100 cites·20 claims
- 3685US2024041897A1Prodrug comprising a drug linker conjugateASCENDIS PHARMA AS·Filed 2023·Application pending·0 cites
- 3782US8986609B2Sterilization of biodegradable hydrogelsRAU HARALD·Filed 2010·Granted Mar 24, 2015·6 cites·16 claims
- 3882US2025121074A1Cnp prodrugs with carrier attachment at the ring moietyASCENDIS PHARMA GROWTH DISORDERS AS·Filed 2024·Application pending·0 cites
- 3982US2022331334A1Prodrug Comprising a Drug-Linker ConjugateASCENDIS PHARMA AS·Filed 2022·Application pending·0 cites
- 4080US9265723B2Long acting insulin compositionSPROGOE KENNETT·Filed 2010·Granted Feb 23, 2016·11 cites·50 claims
- 4179US11642415B2Hydrogel cross-linked hyaluronic acid prodrug compositions and methodsASCENDIS PHARMA AS·Filed 2019·Granted May 9, 2023·1 cites·28 claims
- 4279US10029015B2Hydrogel formulationsASCENDIS PHARMA AS·Filed 2015·Granted Jul 24, 2018·2 cites·22 claims
- 4379US9872864B2Sustained release composition of prostacyclinSPROGØE KENNETT·Filed 2012·Granted Jan 23, 2018·6 cites·13 claims
- 4478US9133276B2Prodrugs comprising an exendin linker conjugateCLEEMANN FELIX·Filed 2011·Granted Sep 15, 2015·6 cites·26 claims
- 4578US4281147AProcess for the production of aqueous solutions of alkali organosiliconatesGOLDSCHMIDT AG TH·Filed 1980·Granted Jul 28, 1981·12 cites·8 claims
- 4677US10729778B2Carrier-linked treprostinil prodrugsHERSEL ULRICH·Filed 2017·Granted Aug 4, 2020·1 cites·24 claims
- 4777US2022296682A1Cnp prodrugs with large carrier moietiesASCENDIS PHARMA GROWTH DISORDERS AS·Filed 2021·Application pending·0 cites
- 4877US2025090639A1Controlled-release cnp agonists with low initial npr-b activityASCENDIS PHARMA GROWTH DISORDERS AS·Filed 2024·Application pending·0 cites
- 4976US9561285B2Carrier-linked carbamate prodrug linkersRAU HARALD·Filed 2011·Granted Feb 7, 2017·4 cites·16 claims
- 5076US2020046725A1Prodrug Comprising a Drug Linker ConjugateASCENDIS PHARMA AS·Filed 2019·Application pending·0 cites
Showing the top 50 of 114 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Harald Rau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →